BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34115832)

  • 1. Persistent thrombocytopenia predicts poor long-term survival in patients with antiphospholipid syndrome: a 38-year follow-up study.
    Pardos-Gea J; Marques-Soares JR; Buján S; Ordi-Ros J; Alijotas-Reig J
    Rheumatology (Oxford); 2022 Mar; 61(3):1053-1061. PubMed ID: 34115832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.
    Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
    Br J Haematol; 2013 Jun; 161(5):706-714. PubMed ID: 23530551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenia in primary antiphospholipid syndrome: association with prognosis and clinical implications.
    Shi Y; Zhao J; Jiang H; Huang C; Qi W; Song Y; Wang Q; Li M; Tian X; Zhao Y; Zeng X
    Rheumatology (Oxford); 2022 Dec; 62(1):256-263. PubMed ID: 35536236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding in the antiphospholipid syndrome.
    Forastiero R
    Hematology; 2012 Apr; 17 Suppl 1():S153-5. PubMed ID: 22507807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
    Ma J; Song H; Wei M; He Y
    Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study.
    Pablo RD; Cacho PM; López-Hoyos M; Calvo-Río V; Riancho-Zarrabeitia L; Martínez-Taboada VM
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):354-362. PubMed ID: 34216367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study.
    Comellas-Kirkerup L; Hernández-Molina G; Cabral AR
    Blood; 2010 Oct; 116(16):3058-63. PubMed ID: 20625007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome].
    Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D
    Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features, risk factors, and outcomes of diffuse alveolar hemorrhage in antiphospholipid syndrome: A mixed-method approach combining a multicenter cohort with a systematic literature review.
    Figueroa-Parra G; Meade-Aguilar JA; Langenfeld HE; González-Treviño M; Hocaoglu M; Hanson AC; Prokop LJ; Murad MH; Cartin-Ceba R; Specks U; Majithia V; Crowson CS; Duarte-García A
    Clin Immunol; 2023 Nov; 256():109775. PubMed ID: 37722463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia in high-risk patients with antiphospholipid syndrome.
    Pontara E; Banzato A; Bison E; Cattini MG; Baroni G; Denas G; Calligaro A; Marson P; Tison T; Ruffatti A; Pengo V
    J Thromb Haemost; 2018 Mar; 16(3):529-532. PubMed ID: 29316193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
    Amory CF; Levine SR; Brey RL; Gebregziabher M; Tuhrim S; Tilley BC; Simpson AC; Sacco RL; Mohr JP;
    Cerebrovasc Dis; 2015; 40(5-6):293-300. PubMed ID: 26513489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.
    Tarr T; Lakos G; Bhattoa HP; Soltesz P; Shoenfeld Y; Szegedi G; Kiss E
    Clin Rev Allergy Immunol; 2007 Apr; 32(2):131-7. PubMed ID: 17916982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia in antiphospholipid syndrome: Is anticoagulation and/or antiaggregation always required?
    Zuily S; Cervera R; Foret T; Bertocchi S; Tincani A
    Autoimmun Rev; 2024 Jan; 23(1):103417. PubMed ID: 37619905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.